Dark Forest Capital Management LP Kymera Therapeutics, Inc. Transaction History
Dark Forest Capital Management LP
- $634 Million
- Q4 2024
A detailed history of Dark Forest Capital Management LP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Dark Forest Capital Management LP holds 10,249 shares of KYMR stock, worth $321,306. This represents 0.06% of its overall portfolio holdings.
Number of Shares
10,249
Previous 4,410
132.4%
Holding current value
$321,306
Previous $208,000
98.08%
% of portfolio
0.06%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding KYMR
# of Institutions
186Shares Held
65.6MCall Options Held
49.6KPut Options Held
17K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$215 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$188 Million2.67% of portfolio
-
Wellington Management Group LLP Boston, MA5.31MShares$166 Million0.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$162 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$161 Million3.02% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.72B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...